Apeiron Investment Group Ltd. 13D and 13G filings for Sensei Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-02 5:00 pm Sale |
2023-06-01 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 0 0.000% |
-3,441,661 (Position Closed) |
Filing |
| 2023-05-23 4:50 pm Unchanged |
2023-05-23 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,441,661 11.100% |
0 (Unchanged) |
Filing |
| 2023-03-09 5:15 pm Purchase |
2023-03-09 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,441,661 11.200% |
2,200 (+0.06%) |
Filing |
| 2022-11-21 06:15 am Unchanged |
2022-11-21 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,439,461 11.200% |
0 (Unchanged) |
Filing |
| 2022-11-02 11:58 am Unchanged |
2022-11-02 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,439,461 11.200% |
0 (Unchanged) |
Filing |
| 2022-07-19 5:30 pm Purchase |
2022-07-14 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,439,461 11.200% |
210,000 (+6.50%) |
Filing |
| 2022-02-10 5:15 pm Purchase |
2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,229,461 10.600% |
577,618 (+21.78%) |
Filing |
| 2021-02-18 4:15 pm Purchase |
2021-02-08 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 2,651,843 8.700% |
2,651,843 (New Position) |
Filing |